Transplantation options for therapeutic central nervous system remyelination.
about
Baculovirus-mediated gene delivery into Mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression.Ectopic expression of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes their migration and remyelination potential in the central nervous systemOligodendrogenesis in the subventricular zone and the role of epidermal growth factorEpidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes.Extensive cell migration, axon regeneration, and improved function with polysialic acid-modified Schwann cells after spinal cord injury.Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitors.Transplantation of mouse embryonic stem cell-derived oligodendrocytes in the murine model of globoid cell leukodystrophy.Cell therapy for multiple sclerosis.A quantitative morphometric analysis of rat spinal cord remyelination following transplantation of allogenic Schwann cells.Manipulation of Schwann cell migration across the astrocyte boundary by polysialyltransferase-loaded superparamagnetic nanoparticles under magnetic fieldNGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes.Purification and Characterization of Schwann Cells from Adult Human Skin and Nerve.Transdifferentiation of Human Dental Pulp Stem Cells Into Oligoprogenitor Cells.
P2860
Q24543324-28F8D405-07C2-445E-B987-C5ED6CE6856EQ30493156-5A5A2738-CD67-4659-8231-10E34AAAD150Q34159075-72FEEDAE-72B5-4819-800B-383AE56FF418Q34988134-2EF6C89F-9A79-481E-9F18-1F53AE70008EQ35295364-3B0FA8E0-01A6-4852-B84E-25C4D2125FF8Q35394635-1E9BC213-D89E-4751-B9DB-2E19014DDDC3Q35549843-9D3525E3-E4A0-415A-A588-1CCCAB7D9CE1Q35648117-D8E35E91-134A-4599-8BAE-2F6BD754C9C5Q37020033-E810CA89-06B0-47D5-BEC2-D3395FCB74FFQ37509976-EEA7D2E0-947B-4F74-9217-6CFB169A7001Q41950217-D9180EDF-DAD3-4F7A-849F-1BEAB4A6C000Q42143105-0CC4A7B7-9D6E-4278-A41F-6550B21E8DF8Q45207150-F14189EA-8844-4B49-93C4-E80DA12653FB
P2860
Transplantation options for therapeutic central nervous system remyelination.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Transplantation options for therapeutic central nervous system remyelination.
@ast
Transplantation options for therapeutic central nervous system remyelination.
@en
type
label
Transplantation options for therapeutic central nervous system remyelination.
@ast
Transplantation options for therapeutic central nervous system remyelination.
@en
prefLabel
Transplantation options for therapeutic central nervous system remyelination.
@ast
Transplantation options for therapeutic central nervous system remyelination.
@en
P1433
P1476
Transplantation options for therapeutic central nervous system remyelination.
@en
P2093
Blakemore WF
Franklin RJ
P304
P577
2000-03-01T00:00:00Z